CNW/ -- (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating ...

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

The administration cited concerns about mRNA technology; however, Moderna says the vaccine causes a "rapid, potent and ...

The first bacteria our bodies meet – in the hours after we're born – could protect us from dangerous infections, UK ...

A substantial burden of hospitalizations for PIV-associated ARI was observed among pediatric patients in the United States.

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

The current uptick in COVID-19 in Asia and India seems to follow an emerging seasonal pattern of SARS-CoV-2’ | Photo Credit: ...

Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved ...